Refractory hypokalemia caused by cetuximab with advanced colorectal cancer patients: the case series and literature review

Cetuximab is the first-line treatment for advanced metastatic colon cancer. But cetuximab can cause electrolyte disturbances, including hypomagnesemia and hypokalemia. Among them, hypokalemia is often caused by hypomagnesemia, not directly caused by cetuximab. This article reports two cases of refra...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yun-Wang, Yang, Min, Wang, Ming-Xing, Jiang, Jia-Hong, Jiang, Ding-Yi, Chen, Zhe-Ling, Yang, Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2021
Materias:
Case Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670339/
https://www.ncbi.nlm.nih.gov/pubmed/34419963
http://dx.doi.org/10.1097/CAD.0000000000001212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8670339/
https://www.ncbi.nlm.nih.gov/pubmed/34419963
http://dx.doi.org/10.1097/CAD.0000000000001212

Ejemplares similares